Showing results (631-640 of 2,891) with videos related to

Sort By:
Pageof 290
Heart Rhythm|May 5, 2025
Prediction of ischemic stroke by the CHA2DS2-VA score in an Asian population: A report from the prospective nationwide COOL-AF registryRungroj Krittayaphong, Sirin Apiyasawat, Komsing Methavigul, et al.
Life (Basel, Switzerland)|September 28, 2023
Artificial Intelligence in the Image-Guided Care of Atrial FibrillationYiheng Lyu, Mohammed Bennamoun, Naeha Sharif, et al.
Pacing and Clinical Electrophysiology : PACE|July 1, 2026
Sex Differences in the Burden of Atrial Fibrillation/Flutter and Associated Heart Failure Stratified by Age at OnsetZijie Ding, Xu Tian, Jinhua Zhao, et al.
JACC. Advances|August 5, 2026
Obesity Subphenotypes in Atrial Fibrillation: A Linked Electronic Health Record Study in the United KingdomHiroyuki Yoshimura, Chang Xu, Gregory Y H Lip, et al.
European Journal of Heart Failure|February 11, 2005
Ambulatory blood pressure monitoring in heart failure: a systematic reviewDeepak Goyal, Robert J Macfadyen, Robert D Watson, et al.
Thrombosis and Haemostasis|March 18, 2025
Latent Class Analysis for the Identification of Phenotypes Associated with Increased Risk in Atrial Fibrillation Patients: The COOL-AF RegistryRungroj Krittayaphong, Sukrit Treewaree, Ahthit Yindeengam, et al.
Cancer|October 10, 2003
Coagulopathic complications in breast cancerGraham J Caine, Paul S Stonelake, Daniel Rea, et al.
Mayo Clinic Proceedings|December 16, 2018
Integrated Care Management of Patients With Atrial Fibrillation and Risk of Cardiovascular Events: The ABC (Atrial fibrillation Better Care) Pathway in the ATHERO-AF Study CohortDaniele Pastori, Pasquale Pignatelli, Danilo Menichelli, et al.
Journal of the American Heart Association|February 6, 2019
Short-Term Outcomes in Newly Diagnosed Atrial Fibrillation and Chronic Kidney Disease: How Important Is Ethnicity?Wern Yew Ding, Ahsan A Khan, Dhiraj Gupta, et al.
Thrombosis and Haemostasis|March 1, 2014
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysisFlemming Skjøth, Torben Bjerregaard Larsen, Lars Hvilsted Rasmussen, et al.
Pageof 290